A Genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds. Conversely, we could avoid these drugs if we knew a patient was unlikely to benefit from their use.

If you would like to read more about this study via Stanford Medicine, click the link below.

http://med.stanford.edu/news/all-news/2019/11/genetic-_fingerprint-may-id-breast-cancer-patients-likely-to-ben.html?fbclid=IwAR2WwjX6SzgZCBkIdO999FPMBM92bUuHyBbMhwWf5nySznZTw4DNqCUusK4